Jump to main content
Jump to site search

Issue 35, 2018
Previous Article Next Article

Lipid-coated mesoporous silica microparticles for the controlled delivery of β-galactosidase into intestines

Author affiliations

Abstract

β-Galactosidase has been drawing increasing attention for the treatment of lactose intolerance, but its delivery has been impeded by degradation under gastric conditions. We have demonstrated that the coating of mesoporous silica microparticles (diameter ≈ 9 µm, pore size ≈ 25 nm) with dioleoylphosphatidylcholine membranes significantly improved the loading capability and protected the enzymes from the loss of function under simulated gastric conditions. Once the particles are transferred to simulated intestinal conditions, the digestion of phosphatidylcholine with pancreatin led to the release of functional β-galactosidase. The coating of mesoporous silica nanoparticles with a single phospholipid bilayer opens up a large potential towards the controlled release of orally administrated drugs or enzymes to the intestines.

Graphical abstract: Lipid-coated mesoporous silica microparticles for the controlled delivery of β-galactosidase into intestines

Back to tab navigation

Supplementary files

Publication details

The article was received on 27 Apr 2018, accepted on 06 Aug 2018 and first published on 07 Aug 2018


Article type: Paper
DOI: 10.1039/C8TB01114A
Citation: J. Mater. Chem. B, 2018,6, 5633-5639
  •   Request permissions

    Lipid-coated mesoporous silica microparticles for the controlled delivery of β-galactosidase into intestines

    I. Pavel, M. Girardon, S. El Hajj, S. Parant, F. Amadei, S. Kaufmann, M. Tanaka, V. Fierro, A. Celzard, N. Canilho and A. Pasc, J. Mater. Chem. B, 2018, 6, 5633
    DOI: 10.1039/C8TB01114A

Search articles by author

Spotlight

Advertisements